These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 30539201)
1. Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the Pelvic Organ Prolapse Quantification system. Gava G; Alvisi S; Mancini I; Seracchioli R; Meriggiola MC Int Urogynecol J; 2019 Nov; 30(11):1911-1917. PubMed ID: 30539201 [TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome and pelvic organ prolapse severity. Rogowski A; Bienkowski P; Tarwacki D; Dziech E; Samochowiec J; Jerzak M; Baranowski W Int Urogynecol J; 2015 Apr; 26(4):563-8. PubMed ID: 25047898 [TBL] [Abstract][Full Text] [Related]
3. Defecatory dysfunction and fecal incontinence in women with or without posterior vaginal wall prolapse as measured by pelvic organ prolapse quantification (POP-Q). Augusto KL; Bezerra LRPS; Murad-Regadas SM; Vasconcelos Neto JA; Vasconcelos CTM; Karbage SAL; Bilhar APM; Regadas FSP Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():50-55. PubMed ID: 28477524 [TBL] [Abstract][Full Text] [Related]
4. A nationwide population-based survey on the prevalence and risk factors of symptomatic pelvic organ prolapse in adult women in China - a pelvic organ prolapse quantification system-based study. Pang H; Zhang L; Han S; Li Z; Gong J; Liu Q; Liu X; Wang J; Xia Z; Lang J; Xu T; Zhu L BJOG; 2021 Jul; 128(8):1313-1323. PubMed ID: 33619817 [TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms screening in postmenopausal women with symptomatic pelvic organ prolapse. Ai F; Deng M; Mao M; Xu T; Zhu L Menopause; 2018 Mar; 25(3):314-319. PubMed ID: 29040216 [TBL] [Abstract][Full Text] [Related]
6. Severity and bother of prolapse symptoms in women with pelvic floor myofascial pain. Dixon AM; Fitzgerald CM; Brincat C Int Urogynecol J; 2019 Nov; 30(11):1829-1834. PubMed ID: 30874833 [TBL] [Abstract][Full Text] [Related]
7. The effect of episiotomy on pelvic organ prolapse assessed by pelvic organ prolapse quantification system. Aytan H; Tok EC; Ertunc D; Yasa O Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():34-7. PubMed ID: 24314799 [TBL] [Abstract][Full Text] [Related]
8. Association between pelvic floor muscle trauma and pelvic organ prolapse 20 years after delivery. Volløyhaug I; Mørkved S; Salvesen KÅ Int Urogynecol J; 2016 Jan; 27(1):39-45. PubMed ID: 26198007 [TBL] [Abstract][Full Text] [Related]
9. Pelvic floor symptoms and severity of pelvic organ prolapse in women seeking care for pelvic floor problems. Espuña-Pons M; Fillol M; Pascual MA; Rebollo P; Mora AM; Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():141-5. PubMed ID: 24784712 [TBL] [Abstract][Full Text] [Related]
10. Screening for general anxiety disorders in postmenopausal women with symptomatic pelvic organ prolapse. Ai F; Deng M; Mao M; Xu T; Zhu L Climacteric; 2018 Feb; 21(1):35-39. PubMed ID: 29095064 [TBL] [Abstract][Full Text] [Related]
11. Putting POP-Q to the test: does C - D = cervical length? Williams KS; Rosen L; Pilkinton ML; Dhariwal L; Winkler HA Int Urogynecol J; 2018 Jun; 29(6):881-885. PubMed ID: 28871354 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of assessing Pelvic Organ Prolapse Quantification points using dynamic 2D transperineal ultrasound in women with pelvic organ prolapse. Lone FW; Thakar R; Sultan AH; Stankiewicz A Int Urogynecol J; 2012 Nov; 23(11):1555-60. PubMed ID: 22543548 [TBL] [Abstract][Full Text] [Related]
13. Comparison of transperineal ultrasound with POP-Q for assessing symptoms of prolapse. Volløyhaug I; Rojas RG; Mørkved S; Salvesen KÅ Int Urogynecol J; 2019 Apr; 30(4):595-602. PubMed ID: 30069728 [TBL] [Abstract][Full Text] [Related]
14. Turkish adaptation of the Pelvic Organ Prolapse Symptom Score and its validity and reliability. Özengin N; Kaya S; Orhan C; Bakar Y; Duran B; Ankaralı H; Akbayrak T Int Urogynecol J; 2017 Aug; 28(8):1217-1222. PubMed ID: 28062904 [TBL] [Abstract][Full Text] [Related]
15. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Horst W; do Valle JB; Silva JC; Gascho CLL Int Urogynecol J; 2017 Aug; 28(8):1165-1170. PubMed ID: 28035442 [TBL] [Abstract][Full Text] [Related]
16. [Utilize the simplified POP-Q system in the clinical practice of staging for pelvic organ prolapse: comparative analysis with standard POP-Q system]. Zhang H; Zhu L; Xu T; Lang JH Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):510-4. PubMed ID: 27465870 [TBL] [Abstract][Full Text] [Related]
17. A review of the pelvic organ prolapse quantification system in China. Wang YT; Jiang JY; Han JS Int Urogynecol J; 2016 Feb; 27(2):287-90. PubMed ID: 26353847 [TBL] [Abstract][Full Text] [Related]
18. Pelvic organ prolapse and Japanese lifestyle: prevalence and risk factors in Japan. Kato J; Nagata C; Miwa K; Ito N; Morishige KI Int Urogynecol J; 2022 Jan; 33(1):47-51. PubMed ID: 33580329 [TBL] [Abstract][Full Text] [Related]
19. The role of tenascin-X in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse: an immunohistochemical study. Bodner-Adler B; Bodner K; Kimberger O; Halpern K; Schneidinger C; Haslinger P; Schneeberger C; Horvat R; Umek W Int Urogynecol J; 2020 Jan; 31(1):101-106. PubMed ID: 30535979 [TBL] [Abstract][Full Text] [Related]
20. Forceps delivery is associated with increased risk of pelvic organ prolapse and muscle trauma: a cross-sectional study 16-24 years after first delivery. Volløyhaug I; Mørkved S; Salvesen Ø; Salvesen KÅ Ultrasound Obstet Gynecol; 2015 Oct; 46(4):487-95. PubMed ID: 25920322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]